IMMUCELL CORP /DE/ Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Immucell Corp /De/ quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Immucell Corp /De/ Debt-to-equity for the quarter ending September 30, 2024 was 74 %, a 26.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 74 +15.6 +26.7% Sep 30, 2024
Q2 2024 74.8 +22.9 +44% Jun 30, 2024
Q1 2024 71.1 +24.6 +52.8% Mar 31, 2024
Q4 2023 65.5 +21.9 +50.1% Dec 31, 2023
Q3 2023 58.5 +17.5 +42.9% Sep 30, 2023
Q2 2023 52 +13.3 +34.2% Jun 30, 2023
Q1 2023 46.6 +9.24 +24.8% Mar 31, 2023
Q4 2022 43.6 +6.19 +16.5% Dec 31, 2022
Q3 2022 40.9 +1.97 +5.06% Sep 30, 2022
Q2 2022 38.7 -1.86 -4.58% Jun 30, 2022
Q1 2022 37.3 -5.54 -12.9% Mar 31, 2022
Q4 2021 37.4 -4.38 -10.5% Dec 31, 2021
Q3 2021 38.9 -0.53 -1.34% Sep 30, 2021
Q2 2021 40.6 +3.52 +9.49% Jun 30, 2021
Q1 2021 42.9 +8.45 +24.6% Mar 31, 2021
Q4 2020 41.8 +8.49 +25.5% Dec 31, 2020
Q3 2020 39.5 +2.8 +7.64% Sep 30, 2020
Q2 2020 37.1 -2.75 -6.91% Jun 30, 2020
Q1 2020 34.4 -8.38 -19.6% Mar 31, 2020
Q4 2019 33.3 -12.5 -27.3% Dec 31, 2019
Q3 2019 36.7 -7.98 -17.9% Sep 30, 2019
Q2 2019 39.8 -4.32 -9.79% Jun 30, 2019
Q1 2019 42.8 -0.33 -0.77% Mar 31, 2019
Q4 2018 45.9 +7.25 +18.8% Dec 31, 2018
Q3 2018 44.7 +11.2 +33.6% Sep 30, 2018
Q2 2018 44.1 +15.5 +54.1% Jun 30, 2018
Q1 2018 43.1 +17.9 +70.8% Mar 31, 2018
Q4 2017 38.6 +13.2 +52% Dec 31, 2017
Q3 2017 33.4 +5.88 +21.4% Sep 30, 2017
Q2 2017 28.7 -1.56 -5.16% Jun 30, 2017
Q1 2017 25.2 -2.86 -10.2% Mar 31, 2017
Q4 2016 25.4 -0.91 -3.46% Dec 31, 2016
Q3 2016 27.5 +5.74 +26.3% Sep 30, 2016
Q2 2016 30.2 +13.8 +84.3% Jun 30, 2016
Q1 2016 28.1 +10.5 +59.5% Mar 31, 2016
Q4 2015 26.3 +7.88 +42.7% Dec 31, 2015
Q3 2015 21.8 +4.04 +22.8% Sep 30, 2015
Q2 2015 16.4 -1 -5.75% Jun 30, 2015
Q1 2015 17.6 -0.32 -1.78% Mar 31, 2015
Q4 2014 18.4 +0.57 +3.19% Dec 31, 2014
Q3 2014 17.8 -0.93 -4.98% Sep 30, 2014
Q2 2014 17.4 -2.02 -10.4% Jun 30, 2014
Q1 2014 17.9 -1.17 -6.12% Mar 31, 2014
Q4 2013 17.9 -1.95 -9.84% Dec 31, 2013
Q3 2013 18.7 -1.59 -7.84% Sep 30, 2013
Q2 2013 19.4 -1.55 -7.39% Jun 30, 2013
Q1 2013 19.1 -3.26 -14.6% Mar 31, 2013
Q4 2012 19.8 Dec 31, 2012
Q3 2012 20.3 Sep 30, 2012
Q2 2012 21 Jun 30, 2012
Q1 2012 22.4 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.